Amoy Diagnostics Co Ltd
SZSE:300685
Amoy Diagnostics Co Ltd
Cash from Operating Activities
Amoy Diagnostics Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amoy Diagnostics Co Ltd
SZSE:300685
|
Cash from Operating Activities
¥298.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Operating Activities
-¥7.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Operating Activities
-¥1.7B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Operating Activities
¥1.5B
|
CAGR 3-Years
49%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Cash from Operating Activities
¥2.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
55%
|
CAGR 10-Years
34%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Operating Activities
¥3.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
106%
|
CAGR 10-Years
47%
|
See Also
What is Amoy Diagnostics Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
298.7m
CNY
Based on the financial report for Dec 31, 2023, Amoy Diagnostics Co Ltd's Cash from Operating Activities amounts to 298.7m CNY.
What is Amoy Diagnostics Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
26%
Over the last year, the Cash from Operating Activities growth was 100%. The average annual Cash from Operating Activities growth rates for Amoy Diagnostics Co Ltd have been 11% over the past three years , 26% over the past five years .